Redox Profiling Reveals Clear Differences between Molecular Patterns of Wound Fluids from Acute and Chronic Wounds by Bodnár, Edina et al.
Research Article
Redox Profiling Reveals Clear Differences between Molecular
Patterns of Wound Fluids from Acute and Chronic Wounds
Edina Bodnár,1 Edina Bakondi,2 Katalin Kovács,3 Csaba Hegedűs,2 Petra Lakatos,2
Agnieszka Robaszkiewicz,4 Zsolt Regdon,2 László Virág ,2,3 and Éva Szabó 1
1Department of Dermatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary
2Department of Medical Chemistry, Faculty of Medicine, University of Debrecen, Debrecen, Hungary
3MTA-DE Cell Biology and Signaling Research Group, Debrecen, Hungary
4Department of General Biophysics, University of Łódź, Łódź, Poland
Correspondence should be addressed to László Virág; lvirag@med.unideb.hu and Éva Szabó; eszabo@med.unideb.hu
Received 19 July 2018; Accepted 23 September 2018; Published 18 November 2018
Academic Editor: Kota V. Ramana
Copyright © 2018 Edina Bodnár et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Wound healing is a complex multiphase process which can be hampered by many factors including impaired local circulation,
hypoxia, infection, malnutrition, immunosuppression, and metabolic dysregulation in diabetes. Redox dysregulation is a
common feature of many skin diseases demonstrated by virtually all cell types in the skin with overproduction of reactive
oxygen and nitrogen species. The objective of this study was to characterize the redox environment in wound ﬂuids and sera
from patients suﬀering from chronic leg ulcers (n = 19) and acute wounds (bulla ﬂuids from second degree burns; n = 11) with
serum data also compared to those from healthy volunteers (n = 7). Signiﬁcantly higher concentrations of TNF-α, interleukine-
8, vascular endothelial growth factor, and lactate dehydrogenase (measure of cell damage) were found in ﬂuids from chronic
wounds compared to acute ones. The extent of protein carbonylation (measure of protein oxidation), lipid peroxidation, and
tyrosine nitration (indicator of peroxynitrite production) was similar in acute and chronic wound ﬂuids, while radical
scavenging activity and glutathione (GSH) levels were elevated in chronic wound ﬂuids compared to acute wounds. Sera were
also assessed for the same set of parameters with no signiﬁcant diﬀerences detected. Nitrotyrosine (the footprint of the potent
oxidant peroxynitrite) and poly(ADP-ribose) (the product of the DNA damage sensor enzyme PARP-1) could be detected in
wound biopsies. Our data identify multiple signs of redox stress in chronic wounds with notable diﬀerences. In chronic
wounds, elevations in antioxidant levels/activities may indicate compensatory mechanisms against inﬂammation. The
presence of nitrotyrosine and poly(ADP-ribose) in tissues from venous leg ulcers indicate peroxynitrite production and
PARP activation in chronic wounds.
1. Introduction
According to the World Health Organization (WHO),
injuries account for 9% of global mortality with much higher
numbers of associated hospitalizations and emergency
department visits [1] compared to other causes of mortality.
Many of the injuries are accompanied by skin wounds.
While skin wounds caused by accidental or surgical cuts
typically heal well, other types of dermatological ulcers
(discontinuities of the skin) such as diabetic ulcers or
pressure ulcers pose a real challenge in terms of successful
wound management [2].
Wound healing can be delayed by various factors, includ-
ing infections, impaired local circulation, hypoxia, venous
stasis, nutritional problems, tension on wound edges, chronic
inﬂammation, immunosuppression, and metabolic dysregu-
lation due to diabetes. Because of the high incidence of diabe-
tes in Western populations proper metabolic control of
diabetics is of the utmost importance for the prevention of
diabetic ulcers. Of note, 5% of diabetic patients develop foot
ulcers and 1% require amputation [3].
Wound healing proceeds through four phases: hemosta-
sis, inﬂammation, proliferation, and remodeling. Although
the complex events of wound healing have been histologically
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well characterized, a comprehensive understanding of the
biochemical and cellular events controlling normal and path-
ological wound healing is lacking.
Disruption of redox homeostasis is a common feature of
various pathological conditions [4]. Reactive oxygen and
nitrogen species (ROS and RNS, respectively) are produced
by virtually all cells and tissues. Sources of ROS and RNS
include the mitochondrial respiratory chain, autoxidation
processes, NADPH oxidase, and nitric oxide synthase
(NOS) enzymes. The physiological roles of ROS and RNS
include but are not limited to host defense, exercise, vasore-
laxation, oxygen sensing, and regulation of transcription and
cell growth, only to name a few. The physiological signaling
roles of ROS and RNS require redox sensor proteins such as
activator protein 1 (AP-1, a heterodimer of c-Jun and c-Fos),
heat shock factor 1 (HSF-1), or Keap-1. Redox switching
relies on oxidation or glutathionylation of cysteine residues
[5]. Nitric oxide, on the other hand, can regulate protein
function by nitrosation or nitrosylation (e.g., of myocyte
enhancer factor 2 (MEF-2) or guanylate cyclase, respec-
tively) [6]. Moreover, an extensive antioxidant defense
system consisting of small molecular and enzymatic antiox-
idants (e.g., glutathione, superoxide dismutase, catalase, and
glutathione-peroxidase, respectively) operates to prevent
tissue damage caused by ROS/RNS.
In contrast to redox regulation, oxidative stress due to an
imbalance between production and elimination of ROS and
RNS results in damage to proteins, lipids, and DNA. One
particular oxidative stress pathway has received considerable
attention. This oxidative stress pathway relies on the
formation of nitric oxide-derived peroxynitrite (ONOO−),
peroxynitrite-induced DNA strand breakage, and activa-
tion of the DNA break sensor enzyme poly(ADP-ribose)
polymerase (PARP-1, ARTD1) [7]. Peroxynitrite is formed
in a diﬀusion limited reaction between superoxide and
nitric oxide:
NO⋅ +O2 ⋅−→ONOO− 1
Besides triggering lipid peroxidation and protein oxi-
dation and nitration, peroxynitrite is a potent inducer of
DNA single strand breaks (SSB). PARP-1 is rapidly acti-
vated by DNA SSBs and cleaves NAD+ to nicotinamide
and ADP-ribose. PARP1 then attaches ADP-ribose to suit-
able protein acceptors near the DNA nicks and builds a
branched poly-ADP-ribose (PAR) polymer to initiate the
repair process. PAR polymers and NAD consumption
may induce cell dysfunction and cell death as demon-
strated in various pathological conditions such as diabetic
endothelial dysfunction [8], stroke, myocardial ischemia
reperfusion injury, and many forms of inﬂammation. The
nitric oxide-peroxynitrite-PARP activation pathway has
also been implicated in the pathophysiology of many skin
disorders. As for the involvement of this pathway in
wound healing, we and others have demonstrated that
PARP activation delays healing of various types of skin
wounds by regulating keratinocyte migration, suppressing
the production of inﬂammatory mediators, and promoting
angiogenesis [9–12]. NO, on the other hand, has been
shown to improve the histological, histochemical, and
electron-microscopic characteristics of skin wounds in rats
(Shekter AB et al. Nitric Oxide 2005). While NO may be
beneﬁcial, no such positive role for ONOO− has been
demonstrated in disease models: data obtained with perox-
ynitrite decomposition catalyst compounds point towards
a damage-promoting role of this oxidant.
Human data on the role of redox imbalance, as well as the
role of the nitric oxide-peroxynitrite-PARP-inﬂammation-
wound healing axis, are scarce. Therefore, the aim of this
study was to characterize the redox environment in acute
and chronic wounds and to track elements of the
peroxynitrite-PARP activation axis in human wounds. Our
data show increased inﬂammatory activity and upregulated
antioxidant homeostasis in chronic wounds compared to
acute ones. Moreover, we found that peroxynitrite and
PARylation are active in chronic wounds.
2. Methods
2.1. Human Samples. The protocol for collecting human
samples was in accordance with the Declaration of Helsinki
and was approved by the Regional Research Ethics Commit-
tee (RKEB 2695). Patients signed informed consents. Patient
data (gender, age, wound type, and wound area) are
presented in Table 1. Wound ﬂuids were collected from a
total of 30 patients. Wounds of patients with chronic ulcers
(venous leg ulcers (n = 16) and diabetic ulcers (n = 3)) were
covered with ﬁlm bandages, and wound ﬂuids accumulating
over 12 h were collected from underneath the bandage with
a sterile needle and syringe. Fluids from acute wounds were
collected from bullas of patients (n = 11) with second degree
burns by aspirating the ﬂuid with a sterile needle. Samples
from both chronic and acute wounds were centrifuged
(2000xg, 30min), and supernatants were stored at −70°C.
Serum samples were obtained from the peripheral blood of
all 30 patients as well as from healthy controls (n = 7) by rou-
tine technique. Healthy controls underwent minor surgery to
excise benign skin tumors. Tissue samples were obtained
from the chronic leg ulcers (n = 14) in order to exclude
spinocellular carcinoma. Two of the total 16 leg ulcer patients
did not consent to biopsy. All 14 samples were devoid of
tumor. Normal skin samples were also obtained from the
healthy controls.
2.2. Detection of Nitrotyrosine in Tissues. Nitrotyrosine was
detected in formaldehyde-ﬁxed and paraﬃn-embedded
sections as previously described [13]. The rabbit polyclonal
anti-nitrotyrosine antibody (Merck, Budapest, Hungary)
was applied at 1 : 1000 dilution. The secondary antibody
was a biotinylated goat anti-rabbit IgG (supplied with the
Vector Elite kits; Vector Laboratories, Burlingame, CA).
The ABC reagent was prepared and used as recommended
by the manufacturer. Color was developed with nickel-
enhanced DAB substrate followed by counterstaining with
chromotrope dye.
2.3. Detection of PARP Activity and PAR Polymer in Tissues.
Poly(ADP-ribose) the polymer product of the PARP-
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catalyzed reaction was detected with standard immunohis-
tochemical procedure as previously described [14]. Nitro-
tyrosine and PAR stainings were semiquantitatively
evaluated by assigning to each section a visual score (from
0 to three) as follows: 0: negative, 1: less than ¼ of cells
showed weak positivity, 2: 25–50% of cells displayed vary-
ing degrees of positivity, and 3: majority of cells showed
moderate to strong positivity.
2.4. Assessing Radical Scavenging Activity of Wound Fluids.
The antioxidant capacity of wound ﬂuids was assessed with
three methods as detailed below.
2.4.1. Measurement of the Radical Scavenging with ABTS
Decolorization Assay.Measurement of the radical scavenging
activity in samples was performed with the ABTS (2,2′-azi-
nobis-(3-ethylbenzothiazoline-6-sulfonic acid)) decoloriza-
tion assay as described previously [15]. ABTS+ radical
cation was generated by oxidation of ABTS with potassium
persulfate at room temperature overnight in the dark. The
next day, shortly before the experiment, absorbance of the
ABTS+ solution was adjusted with Gly-HCl buﬀer to 1.2 at
405 nm. Samples were diluted 2-fold with PBS and were then
incubated with ABTS+ solution for 30 minutes in 96-well
plates in triplicate. Absorbance was measured with Victor V
[3] multilabel reader (405 nm). Decolorization (i.e., antioxi-
dant capacity) was expressed as a percentage of control.
Positive controls were 3mM NAC and 10μM ascorbic acid,
both displaying 100% antioxidant capacity.
2.4.2. Cupric Ion Reducing Antioxidant Capacity (CUPRAC)
Assay. The CUPRAC assay utilizes copper(II)-neocuproine
(Cu(II)-Nc) reagent as the chromogenic oxidant, which
changes the maximum absorbance after reduction with
antioxidants. Measurement of the antioxidant capacity of
wound ﬂuids was performed as described by Apak et al.
[16] with the following modiﬁcations: 12 μM of Trolox
was used as a positive control, the ﬁnal volume was
Table 1: Clinical data of patients involved in this study.
Patient
ID
Gender Age Wound type
Wound
persisted
for
Total wound
area (cm2)
Patient data
1. f 85
Chronic
venous
3 years 96
2. f 70
Chronic
venous
6 years 378
3. m 54
Chronic
venous
5 years 656
4. f 60
Chronic
venous
4 years 56
5. m 82
Chronic
venous
3 years 327.5
6. m 69
Chronic
venous
40 years 750
7. f 70
Chronic
venous
4 years 447
8. m 83
Chronic
venous
20 years 318
9. m 66
Chronic
venous
3 years 18
10. m 52
Chronic
venous
9 months 104
11. f 82
Chronic
venous
2 years 116
12. f 40
Chronic
venous
4 years 56
13. f 70
Chronic
venous
20 years 32
14. f 68
Chronic
venous
4 years 60
15. m 65
Chronic
venous
1.5 years 180
16. m 46
Chronic
venous
3 years 300
17. m 52
Chronic
diabetic
6 months 80
18. m 68
Chronic
diabetic
1 month 36
19. f 81
Chronic
diabetic
4 years 148
20. f 44
Acute (2nd
degree burn)
<4hours 1500
21. f 61
Acute (2nd
degree burn)
<4hours 225
22. m 42
Acute (2nd
degree burn)
<4hours 1800
23. m 68
Acute (2nd
degree burn)
<4hours 3000
24. m 17
Acute (2nd
degree burn)
<4hours 1950
25. m 47
Acute (2nd
degree burn)
<4hours 150
Table 1: Continued.
Patient
ID
Gender Age Wound type
Wound
persisted
for
Total wound
area (cm2)
26. f 71
Acute (2nd
degree burn)
<4hours 300
27. f 77
Acute (2nd
degree burn)
<4hours 2250
28. m 31
Acute (2nd
degree burn)
<4hours 1500
29. f 18
Acute (2nd
degree burn)
<4hours 1500
30. m 23
Acute (2nd
degree burn)
<4hours 3750
Thirty patients were enrolled in the study; 19 with chronic leg ulcers and 11
patients with second degree burns. In the chronic wound group, 16 patients
had venous ulcers and 3 had diabetic ulcers. Clinical data (age, sex, wound
type, persistence, and total area of wounds) are presented.
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reduced to 100 μL, and the measurements were performed
in 96-well microplates.
2.4.3. Determination of H2O2 Scavenging Activity in Amplex
Red Assay. Hydrogen-peroxide scavenging capacity was
measured using the Amplex Red reagent (Thermo Fisher
Scientiﬁc). Serum or wound ﬂuid/drainage samples were
incubated in 1000x dilution with 1μM H2O2 (Sigma-
Aldrich), 50μM Amplex Red reagent, and 0.1U/mL
horseradish peroxidase (Sigma-Aldrich) in phosphate buﬀ-
ered saline for 30 minutes at room temperature. For each
serum sample, serum blanks were prepared. In the presence
of horseradish peroxidase, H2O2 reacts stoichiometrically
with the Amplex Red reagent (10-acetyl-3,7-dihydroxyphe-
noxazine) to generate the red-ﬂuorescent oxidation product,
resoruﬁn. Fluorescence was read with excitation at 530 nm
and emission at 590nm using a Fluoroskan Ascent FL plate
reader (Labsystems, Vantaa, Finland).
2.5. Glutathione (GSH). Serum was precipitated for 15
minutes with RQB-TCA (10%) solution on ice. After centri-
fugation (5000g, 15min, 4°C), the supernatant was collected
for further analysis. For glutathione estimation, 5μL of the
supernatant was put into a 96-well plate, followed by
addition of 40μL of 1M potassium phosphate buﬀer. After
shaking and a 5 minute incubation at room temperature,
140μL of potassium phosphate buﬀer was added, followed
by 25μL of 0.5% o-phthalaldehyde. The sample was shaken
and incubated for 30 minutes at room temperature. Fluores-
cence was read at excitation 390 nm and emission 460nm.
As a background for each sample, appropriate controls were
used: supernatant and buﬀer incubated with 4μL of 7.5mM
N-ethylmaleimide for 30 minutes at room temperature.
Standard curves were prepared with glutathione. Protein
concentration was determined using the bicinchoninic acid
(BCA) method.
2.6. Determination of Cytokines in Wound Fluids. Amounts
of inﬂammatory proteins were determined in sandwich
ELISA formats using the corresponding Human Mini TMB
ELISA Development Kit (PeproTech, USA) following the
manufacturer’s instructions.
2.7. Quantitation of Protein Carbonylation as a Marker of
Protein Oxidation. From each sample, 20μL was diluted with
distilled water to 200μL. After addition of 50μL of 80% TCA
solution, each sample was vortexed and incubated on ice for 5
minutes. After centrifugation at 13,000xg for 2 minutes,
supernatants were removed and pellets were resuspended in
500μL ice-cold acetone. Incubation for 5 minutes at −20°C
was followed by another centrifugation at 13,000xg for 2
minutes. Acetone was removed, pellets were dissolved in
20μL distilled water, and 15μL of sample was used for further
protein carbonyl analysis using OxyBlot Protein Oxidation
Kit (Millipore) following the manufacturer’s instructions.
After completion of the derivatization step, the obtained
DNP product yield was quantiﬁed spectrophotometrically
by measuring absorbance at 405 nm.
2.8. Quantitation of the Lipid Peroxidation Products
(Thiobarbituric Acid Reactive Species, TBARS). Samples
(10μL) were transferred into microcentrifuge tubes followed
by addition of 10μL 8.1% SDS, 75μL 20% acetic acid, 75μL
TBA (thiobarbituric acid), and 30μL dH2O. The reaction
mixtures were incubated at 95°C for 45min, then 100μL of
each reaction mixture was pipetted into individual wells of
a 96-well plate. Absorbance was read at 532nm.
2.9. Protein Tyrosine Nitration. Protein content of samples
were estimated by BCA reagent. Protein concentration in
each sample was diluted to 20μg/μL. Before the experiment,
nitrocellulose membrane was activated by TBST (50mM
Tris, 0.5M NaCl, 0.05% Tween 20, pH7.4) for 20 minute at
room temperature. Samples (1μL) were spotted onto the
membrane in 3 diﬀerent dilutions (100x, 500x, and 1000x).
The membrane was blocked in 5% nonfat dry milk in TBST
for 1 hour at room temperature. The membrane was then
incubated with an anti-nitrotyrosine primary antibody
(Merck Millipore), which was diluted in 1% milk in TBST
overnight at 4°C. After washing three times with TBST,
the membrane was incubated with peroxidase-conjugated
secondary antibody (goat anti-rabbit IgG, Cell Signaling
Technology) diluted in 1% milk in TBST for 1 hour at
room temperature. To visualize the antibody reaction,
chemiluminescent substrates were added, and chemilumi-
nescent signals were detected using a FluorChem FC2
Imager. Densitometric analysis was carried out using Ima-
geJ software. Nitrotyrosine values were expressed in mol/
μg protein calculated from the values of peroxynitrite-
treated BSA, which were used as a positive control.
2.10. Lactate Dehydrogenase Activity. Lactate dehydrogenase
released from damaged cells was measured with a commer-
cial kit (Roche Applied Science, Mannheim, Germany).
Samples (100μL) were transferred to 96-well ﬂat bottom
plates. Detection reagent (100μL) was added, plates were
incubated (30min), and the absorbance of samples was
measured at 490 nm.
2.11. Statistical Analysis. Primary data are presented on box
and whisker plots showing the medians, the lower and higher
quartiles, and minimum and maximum values. Statistical sig-
niﬁcance was determined using t tests. Signiﬁcance of the
relationship between variables and corresponding correla-
tion coeﬃcients were determined using Spearman two-
tailed correlation analysis tests performed with SigmaPlot
software. P values of less than 0.05 were considered
signiﬁcant.
3. Results
In order to assess redox homeostasis in wound patients,
we have determined footprints of ROS/RNS species and
characterized antioxidant homeostasis in wound ﬂuids
and in sera. ROS and RNS cause many diﬀerent types of
alterations in biomolecules. Most ROS/RNS species can
oxidize proteins resulting in protein carbonylation whereas
oxidative lipid modiﬁcations result in lipid peroxidation.
Antioxidant homeostasis was assessed by determining
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radical scavenging activities and levels of the main antiox-
idant molecule glutathione.
We found detectable levels of biomolecular damage in
wound ﬂuids of venous leg ulcers (Figure 1). However, there
were no signiﬁcant diﬀerences in protein oxidation and pro-
tein tyrosine nitration between the two patient groups (acute
and chronic wounds) (Figures 1(a) and 1(b)). Lipid peroxida-
tion was slightly but signiﬁcantly higher in chronic wound
samples compared to acute ones (Figure 1(c)). Moreover,
radical scavenging activity as well as levels of the main anti-
oxidant glutathione were signiﬁcantly diﬀerent; chronic
wounds contained considerably more antioxidants compared
to acute wound ﬂuids (Figures 1(d) and 1(e)). In sera from
wound patients, no major diﬀerences could be seen between
sera from acute and chronic ulcer patients. However, levels of
protein carbonylation and lipid peroxidation products were
slightly but signiﬁcantly lower in sera of chronic wound
patients compared to healthy controls (Figures 2(a) and
2(c)). Lipid peroxidation products were also lower in sera
from acute wound patients compared to control. Moreover,
no major diﬀerence could be detected in protein tyrosine
nitration in sera from controls and wound patients, but sera
from chronic wound patients showed slightly lower nitrotyr-
osine levels compared to acute ones (Figure 2(b)). Antioxi-
dant levels in the sera of acute or chronic wound patients
were not diﬀerent from those of healthy controls (Figure 3).
Lactate dehydrogenase (LDH) activity indicating tissue
injury, mediators of granulocyte recruitment (IL-8),
inﬂammation (TNF-α), and vascularization (VEGF) were
signiﬁcantly higher in the wound ﬂuids of chronic wound
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Figure 1: Biomolecular damage and antioxidant status in the wound ﬂuids. Wound ﬂuids from acute (burn) wounds and from chronic
wounds of venous leg ulcer and diabetic ulcer patients were compared with respect to protein oxidation (a), protein tyrosine nitration (b),
and lipid peroxidation (c). Total antioxidant activity was assessed with ABTS decolorization assay (d), and the levels of the main thiol
antioxidant glutathione were also determined (e). (∗p < 0 05; ∗∗p < 0 01; ∗∗∗p < 0 001).
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Figure 2: Biomolecular damage markers in the sera of patients. Sera from healthy controls, burn patients (acute), venous leg ulcer and
diabetic ulcer patients (chronic) were compared with respect to protein oxidation (a), protein tyrosine nitration (b), and lipid peroxidation
(c). No signiﬁcant diﬀerences were detected between groups.
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Figure 3: Antioxidant status in the sera of patients. Sera from healthy individuals (control), burn patients (acute), venous leg ulcer and
diabetic ulcer patients (chronic) were compared with respect to antioxidant status. Antioxidant activity was assessed with ABTS
decolorization assay (a), Amplex Red assay (b), and Cuprac assay (c). The levels of the main thiol antioxidant, glutathione, was also
determined (d). No signiﬁcant diﬀerences were detected between the groups.
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patients compared to acute ones (Figure 4(a)–(d)). These
biomarkers were not detectable in the sera of patients
(not shown).
A pairwise correlation of all measured biochemical
parameters was also performed. A signiﬁcant correlation
was established in the sera of chronic wound patients
between protein carbonylation and lipid peroxidation
(Figure 5(a)). Moreover, in chronic wound ﬂuids, VEGF
and TNF-α levels also correlated signiﬁcantly with each other
(Figure 5(b)). Furthermore, in the sera of acute wound
patients, a positive correlation was found between lipid per-
oxidation and glutathione levels (Figure 5(c)), while an
inverse correlation could be established between tyrosine
nitration and radical scavenging activity (Figure 5(d)).
3.1. Detection of Nitrotyrosine and Poly(ADP-Ribose) (PAR)
in Tissue Samples. Tissue biopsies were obtained from the
wound area of venous leg ulcer patients in order to exclude
the occurrence of malignancy (malignancies were not
detected in any of the tissue samples). Sections from these
tissues were stained for nitrotyrosine and PAR in order to
verify in vivo production of peroxynitrite (the footprint of
which is nitrotyrosine) and activation of PARP-1 (the
product of which is PAR polymer). We found that wound
areas in samples from venous leg ulcer patients extensively
stained positive for both nitrotyrosine and PAR
(Figures 6(c) and 6(d)). Healthy skin areas of patients who
had no ulcer and underwent biopsies for naevus removal
had no staining or weak positive staining for nitrotyrosine
and PAR (Figure 6(a), 6(b)). Semiquantitative analysis
revealed signiﬁcantly elevated nitrotyrosine and PAR
staining in the wound beds and surrounding tissue compared
to tissues from healthy controls (Figure 6(e)).
4. Discussion
The wound healing process requires a highly orchestrated
sequence of events carefully coordinated both in time and
space. Reactive oxygen and nitrogen intermediates have been
implicated in the regulation of wound healing, both promot-
ing and inhibiting healing, according to published studies
[17]. For example, ROS/RNS species play a crucial signaling
role in the healing process (e.g., in cell proliferation and
angiogenesis) and also contribute to defense against invading
pathogens. In contrast, oxidative stress resulting from an
imbalance between the production and elimination of reac-
tive species clearly contributes to delayed healing of wounds,
as observed in patients with diabetes or patients treated with
chemotherapy, radiotherapy, or anti-inﬂammatory glucocor-
ticoids. How and why the redox environment in acute and
chronic wounds diﬀer from each other is not fully under-
stood. Furthermore, the mechanism by which changes in
the redox environment in wounded tissues are mirrored in
the serum is unknown.
ROS/RNS species may hit important biological targets
(proteins, lipids, and nucleic acids) in tissues and leave their
footprints on biomolecules. Many ROS/RNS species are
oxidants and can cause protein oxidation in tissues. We have
detected protein carbonylation (a protein oxidation marker)
in the wound ﬂuids from acute and chronic wounds with
no signiﬁcant diﬀerence between the acute and chronic
⁎
Acute Chronic
O
D
 ×
 1
00
0
LDH
0
500
1000
1500
(a)
⁎⁎⁎
Acute Chronic
VEGF
pg
/m
l
0
1000
2000
3000
(b)
⁎⁎⁎
Acute Chronic
IL-8
pg
/m
l
0
1000
2000
(c)
⁎⁎⁎
Acute Chronic
TNF-훼
pg
/m
l
0
1000
2000
3000
4000
(d)
Figure 4: Markers of chemoattraction, inﬂammation, vascularization, and tissue damage in wound ﬂuids. Wound ﬂuids from venous ulcers
and diabetic wounds (chronic) and burn wounds (acute) were analyzed for markers of (a) tissue damage (LDH), (b) vascularization (VEGF),
(c) granulocyte chemoattraction (IL-8), and (d) inﬂammation (TNF-α). (∗∗ p < 0 01; ∗∗∗p < 0 001).
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conditions. Lipid peroxidation was slightly more intense in
chronic wound ﬂuids while tyrosine nitration (for example,
caused by peroxynitrite-induced protein modiﬁcation) was
not diﬀerent between the two groups. The antioxidant proﬁle
of acute and chronic wounds; however, diﬀered signiﬁcantly:
chronic wounds had higher radical scavenging activity and
higher GSH content compared to acute wounds. In parallel,
levels of VEGF, a key mediator of vascularization, IL-8, the
main granulocyte recruitment factor, and TNF-α, an inﬂam-
matory cytokine, had higher levels in chronic compared to
acute wounds. These data collectively suggest a more
profound inﬂammatory environment in the chronic wounds
which is likely to be accompanied by higher production of
ROS/RNS species. A compensatory overproduction of
antioxidants (Figures 1(a) and 1(e)) may explain why
increased ROS/RNS production is not reﬂected in accelerated
biomolecule damage (Figures 1(a)–1(c)). The slightly but sig-
niﬁcantly higher lipid peroxide levels in chronic wound ﬂuids
likely indicate that the lipids may represent more vulnerable
targets than proteins.
Molecular events taking place in diseased tissues are often
detectable in the bloodstream, setting the stage for the wide-
spread use of laboratory blood tests. We wondered if changes
in tissue redox environment are mirrored by similar changes
in the sera of patients. The lack of any detectable diﬀerences
in radical scavenging activity, glutathione level, protein
oxidation, and lipid peroxidation in the sera of patients
hospitalized for chronic vs. acute wounds (Figures 2 and 3)
suggests that diﬀerences in redox perturbations remain local-
ized in and around the wound area without causing major
diﬀerences between acute and chronic wound patients at
the systemic level. Of note, lipid peroxidation products
displayed lower levels in both acute and chronic patients’
sera compared to controls, which is in sharp contrast to
diﬀerences in opposite signs seen in wound ﬂuids. It is
likely that wound ﬂuids directly mirror tissue level
0 1 2 3 4 5
0
10
20
30 p = 0.0105
r = 0.6196
Protein carbonyl (OD/ml) 
TB
A
RS
 (n
m
ol
/m
l)
Chronic-serum
(a)
0 1000 2000 3000
0
1000
2000
3000
4000
5000 Chronic–wound fluid p = 0.0143
r = 0.6540
VEGF (pg/ml)
TN
F-
훼
 (p
g/
m
l)
(b)
0.0 2.5 5.0 7.5 10.0 12.5 15.0
0.0
2.5
5.0
7.5
10.0 Acute-serum p = 0.0306
r = 0.6636
G
SH
 (휇
M
)
TBARS (nmol/ml)
(c)
0.150 0.175 0.200 0.225 0.250
500
600
700
800
900 p = 0.0128
r = 0.7364
Nitrotyrosine (휇g/mgprot)
Acute-serum
Ra
di
ca
l s
ca
ve
ng
in
g 
(C
up
ra
c)
(O
D
 ×
 1
00
0/
20
 휇
l)
(d)
Figure 5: Correlation analysis of wound ﬂuid and serum biomarkers. Pairwise correlations were performed on all parameters in the study.
Four pairs of parameters yielding signiﬁcant positive ((a)–(c)) or negative (d) correlations are shown.
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biochemical processes, while serum levels are more
aﬀected by clearance mechanisms.
Interestingly, pairwise correlation analysis of the
measured biochemical parameters revealed signiﬁcant
correlations in some pairs (Figure 5). Of note, a positive
correlation between two biomolecular footprints, namely,
lipid peroxides and protein carbonyls, may suggest that the
same kind of oxidative redox environment may trigger these
two modiﬁcations in the sera of venous ulcer patients
(Figure 5(a)). An inverse correlation between radical
scavenging activity and nitrotyrosine formation indicates
that radical scavengers may inhibit tyrosine nitration in the
sera of acute wound patients (Figure 5(d)). The positive
correlation between lipid peroxidation and glutathione in
the sera of acute wound patients (Figure 5(c)) is somewhat
surprising. In numerous oxidative stress-related conditions,
lipid peroxidation typically increases while glutathione levels
drop in the inﬂamed tissues [18]. Other studies reported a
lack of parallel changes in GSH and lipid peroxide levels
[19] indicating a much more complex relationship between
these parameters. In contrast, the reducing eﬀects of the
glutathione “fragments” cysteinylglycine and cysteine have
been shown to contribute to lipid peroxidation induced by
a ferric ion chelate [20]. If levels of these thiols display
changes similar to glutathione, this may explain why GSH
and lipid peroxide levels change in parallel with each other
in the sera of acute wound patients. However, the possibility
that the correlation does not indicate causal relationship
between the two parameters cannot be excluded.
Although VEGF expression is primarily regulated by
hypoxia signaling [21], inﬂammatory cytokines such as
TNF-α and IL-1β and oxidants such as H2O2 have also been
reported to cause upregulation of VEGF [22, 23]. H2O2-
induced VEGF expression has been shown to occur in the
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Figure 6: Immunohistochemical detection of nitrotyrosine and poly(ADP-ribose) in ulcer biopsies. Tissue biopsies from healthy skin ((a),
(b)) and chronic venous ulcers ((c), (d)) were stained for poly(ADP-ribose) ((a), (c)) and nitrotyrosine ((b), (d)). Scale bars represent
200 μm. Immunostainings were evaluated by a semiquantitative visual scoring, as described in the Methods section. (∗∗∗ p < 0 001).
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skin where it promotes wound healing [23]. VEGF induction
by H2O2 appears to be independent of the hypoxia pathway
but inhibitable by the thiol antioxidant N-acetylcysteine
[22, 23]. In our chronic wound ﬂuid samples, TNF-α levels
correlated with VEGF levels. Thus, it seems plausible to
hypothesize that inﬂammatory and oxidative signaling
induce VEGF expression in chronic wounds. Nonetheless,
deciphering the relationship between redox signaling and
VEGF expression requires further investigation.
While analyzing diﬀerences in the redox environment of
acute versus chronic wounds, one should not ignore the fact
that our study populations had diﬀerent age distributions.
Our patient population with chronic wounds had an average
age of 66.5, while the acute wound population had an average
age of 45.4 years. Since the redox environment may change
with age [24, 25], we could exclude the possibility that some
diﬀerences between the two study groups were due to the
diﬀerence in the average age of patients. In fact, some of the
redox and inﬂammatory parameters measured in the study
(ABTS scavenger activity of the serum and TNF-α, IL8, and
VEGF levels in the wound ﬂuid) correlated with age in the
total study population (Supplementary Figure S2). From
these parameters, serum ABTS activity showed no diﬀerence
between the study groups (Figure 3(a)). Since other oxidative
damage parameters showed no age dependency, we consider
it unlikely that the observed signs of redox stress in the
wound ﬂuids were due to the age factor. Levels of TNF-α,
IL8, and VEGF, on the other hand, correlated positively with
age and showed higher values in chronic compared to acute
wound samples. Further investigation with aged-matched
study groups to conﬁrm or disprove the role of age in the
higher TNF-α, IL8, and VEGF levels of the chronic wound
ﬂuids compared to acute ones may be required.
Peroxynitrite formation occurs in many forms of inﬂam-
mation [7]. Our data also prove that peroxynitrite is formed
in human wounds as indicated by detectable levels of nitro-
tyrosine. Immunohistochemistry revealed increased tyrosine
nitration in chronic wounds compared to healthy skin
(Figure 6). This is likely due to the upregulated expression
of inducible nitric oxide synthase [26] in parallel to elevated
superoxide production [27]. Peroxynitrite and hydroxyl
radicals eﬃciently break DNA strands leading to the activa-
tion of PARP-1 [7]. PARP activation in human chronic
wounds was demonstrated by immunodetection of the
enzyme’s product, poly(ADP-ribose). Increased PAR poly-
mer is thought to be mainly due to the activation of basally
expressed PARP-1. However, PARP-1 expression is also
upregulated in the wounds, especially in the wound edges
(Supplementary Figure S1), and contributes to tissue’ PARy-
lation capacity. Increased PARylation may signal DNA repair
following oxidative DNA damage, but may also contribute to
cell damage in severe oxidative stress. The exact role of PAR-
ylation in human wounds requires further investigation.
Overall, we provided a detailed redox characterization of
human chronic and acute wounds. To interpret the diﬀer-
ences between these two types of wound ﬂuids, one needs
to be aware of the following caveats. While the chronic
wounds from which we collected wound ﬂuids were exposed
to the outer environment (apart from the covering bandage)
and must have been populated with their own microbiome,
the blister ﬂuids that served to represent acute wounds were
covered with the blister roof and were sterile. Since our burn
patients typically reached the burn unit within one hour and
their blister ﬂuids were removed within four hours, composi-
tion of these wound ﬂuids were likely to diﬀer from those
obtained at later time points. Moreover, this early drainage
of blisters also prevented reliable diﬀerentiation between
superﬁcial and partial thickness burns. According to the liter-
ature, wound ﬂuid compositions from these two categories
may not be identical [28]. Nonetheless, the redox parameters
measured from these acute wounds displayed relatively little
variations suggesting that our selected burn patient popula-
tion was likely to be quite homogeneous. Other potential
sources of wound ﬂuid (surgical wounds or donor sites
of skin grafts) usually do not provide suﬃcient sample
volume for the high number of assays used in our study.
We also rejected the idea of using ﬂuids from open
wounds, as in our dermatosurgery practice, only wounds
healing by secondary intention are treated openly and
these are all infected wounds.
In conclusion, our data prove that the redox environment
in chronic human wounds clearly diﬀers from acute wounds
as reﬂected by intense inﬂammation accompanied by higher
antioxidant levels. Detailed follow-up studies dissecting the
roles of the individual ROS species and redox signaling
mechanisms operating in chronic wounds may permit more
precisely targeted pharmacological interventions for the
treatment of delayed wound healing in the future. Moreover,
whether a detailed redox and inﬂammatory biomarker proﬁl-
ing of wound ﬂuids or sera can provide predictive biomarkers
for the identiﬁcation of nonhealing wounds remains to be
seen. Peroxynitrite production and PARylation also occur
in chronic wounds, and likely mediate tissue injury. The
precise role of these processes in normal or pathological
wound healing may be the subject of further investigations.
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Supplementary Figure S1: immunohistochemical detection
of poly(ADP-ribose) polymerase-1 in ulcer biopsies. A tissue
biopsy from a chronic venous ulcer was stained for poly(-
ADP-ribose) polymerase-1 (PARP-1). While wound edges
displayed intense immunopositivity for PARP-1, nearby
healthy skin showed weaker PARP-1 expression. The scale
bar represents 200μm. Supplementary Figure S2: correlation
analysis of wound ﬂuid/serum biomarkers and patients’ age.
Correlation was analyzed between the age of patients and all
biochemical parameters measured in the study. Four pairs of
parameters yielding signiﬁcant positive correlations are
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